New York court halts family DNA searches for crime suspects
By Michael R. Sisak,
Associated Press
| 05. 06. 2022
A New York court halted the use of a DNA crimefighting tool that has helped crack cold cases and put murderers behind bars, but has also raised privacy and racial discrimination concerns, because state lawmakers never approved the practice.
Known as familial DNA searching, the technique allows law enforcement agencies to search the state’s DNA databank for close biological relatives of people who have left traces of genetic material at a crime scene.
A panel of judges on a mid-level appeals court ruled Thursday that regulations for the technique were invalid because a state committee implemented them without consent from the Legislature.
Three of the panel’s five members voted to suspend the searches, which were challenged by a group of Black men who worried they could be targeted for investigation because their biological brothers were convicted of crimes and had genetic information stored in the state’s DNA databank.
Judge Judith J. Gische, writing for the majority, noted that familial DNA searching is useful in investigating crimes — including in identifying serial killers in Kansas and California and a recent...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...